Related references
Note: Only part of the references are listed.Peptide-guided nanoparticles for glioblastoma targeting
Pille Saalik et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery
Prakash Lingasamy et al.
BIOMATERIALS (2019)
Tumor-targeting Peptides: Ligands for Molecular Imaging and Therapy
Ning Zhao et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2018)
Chemotherapeutic drug delivery by tumoral extracellular matrix targeting
Rene Raave et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Tumor Microenvironment Targeted Nanotherapy
Clara Fernandes et al.
FRONTIERS IN PHARMACOLOGY (2018)
Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth
Shweta Sharma et al.
NANO LETTERS (2017)
Hyaluronan-binding peptide for targeting peritoneal carcinomatosis
Hideki Ikemoto et al.
TUMOR BIOLOGY (2017)
Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment
Ting Kang et al.
BIOMATERIALS (2016)
Urokinase-controlled tumor penetrating peptide
Gary B. Braun et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Targeted silver nanoparticles for ratiometric cell phenotyping
Anne-Mari A. Willmore et al.
NANOSCALE (2016)
Mechanism of hard-nanomaterial clearance by the liver
Kim M. Tsoi et al.
NATURE MATERIALS (2016)
Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma
Sebastien Bougnaud et al.
ONCOTARGET (2016)
Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
Christian Schmithals et al.
CANCER RESEARCH (2015)
Peptide therapeutics: current status and future directions
Keld Fosgerau et al.
DRUG DISCOVERY TODAY (2015)
Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy
Huizi Sha et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Tenascin-C: Exploitation and collateral damage in cancer management
Caroline Spenle et al.
CELL ADHESION & MIGRATION (2015)
Targeting ECM disrupts cancer progression
Freja A. Venning et al.
FRONTIERS IN ONCOLOGY (2015)
Budded baculoviruses as a tool for a homogeneous fluorescence anisotropy-based assay of ligand binding to G protein-coupled receptors: The case of melanocortin 4 receptors
Santa Veiksina et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2014)
Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates
Ke Wang et al.
BIOMATERIALS (2014)
Anticancer effects of gemcitabine are enhanced by co-administered iRGD peptide in murine pancreatic cancer models that overexpressed neuropilin-1
Y. Akashi et al.
BRITISH JOURNAL OF CANCER (2014)
The extracellular matrix modulates the hallmarks of cancer
Michael W. Pickup et al.
EMBO REPORTS (2014)
Etchable plasmonic nanoparticle probes to image and quantify cellular internalization
Gary B. Braun et al.
NATURE MATERIALS (2014)
Peritumoral Neuropilin-1 and VEGF receptor-2 expression increases time to recurrence in hepatocellular carcinoma patients undergoing curative hepatectomy
Peng-Yuan Zhuang et al.
ONCOTARGET (2014)
Quantity and accessibility for specific targeting of receptors in tumours
Sajid Hussain et al.
SCIENTIFIC REPORTS (2014)
EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis
Krishna M. Talasila et al.
ACTA NEUROPATHOLOGICA (2013)
The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells
Guangzhi Gu et al.
BIOMATERIALS (2013)
Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
Uma Prabhakar et al.
CANCER RESEARCH (2013)
Tenascin-C is expressed by human glioma in vivo and shows a strong association with tumor blood vessels
Nicole Broesicke et al.
CELL AND TISSUE RESEARCH (2013)
Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles
Erkki Ruoslahti
ADVANCED MATERIALS (2012)
Therapeutic peptides FOREWORD
Fernando Albericio et al.
FUTURE MEDICINAL CHEMISTRY (2012)
The extracellular matrix: A dynamic niche in cancer progression
Pengfei Lu et al.
JOURNAL OF CELL BIOLOGY (2012)
Macromolecular therapeutics in cancer treatment: The EPR effect and beyond
Hiroshi Maeda
JOURNAL OF CONTROLLED RELEASE (2012)
Selection and characterization of tenascin C targeting peptide
Mee Young Kim et al.
MOLECULES AND CELLS (2012)
Transtumoral targeting enabled by a novel neuropilin-binding peptide
L. Roth et al.
ONCOGENE (2012)
MAPPING OF VASCULAR ZIP CODES BY PHAGE DISPLAY
Tambet Teesalu et al.
METHODS IN ENZYMOLOGY: PROTEIN ENGINEERING FOR THERAPEUTICS, VOL 203, PT B (2012)
Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling
Mathieu Berge et al.
JOURNAL OF HEPATOLOGY (2011)
Selection of phage-displayed peptides on live adherent cells in microfluidic channels
Jinpeng Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
Olivier Keunen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
Kazuki N. Sugahara et al.
SCIENCE (2010)
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Kazuki N. Sugahara et al.
CANCER CELL (2009)
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
Tambet Teesalu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Magnetic iron oxide nanoworms for tumor targeting and imaging
Ji-Ho Park et al.
ADVANCED MATERIALS (2008)
Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy
Jessica Marlind et al.
CLINICAL CANCER RESEARCH (2008)
Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats
Michelle Longmire et al.
NANOMEDICINE (2008)
Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo
Michela Silacci et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2006)
A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment
DA Daniels et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma
A Leins et al.
CANCER (2003)
Tenascin-C aptamers are generated using tumor cells and purified protein
BJ Hicke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
